T. K. Sahin Et Al. , "Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61," Anti-Cancer Drugs , vol.31, no.6, pp.609-616, 2020
Sahin, T. K. Et Al. 2020. Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61. Anti-Cancer Drugs , vol.31, no.6 , 609-616.
Sahin, T. K., AKTEPE, O. H., Uckun, F. M., & YALÇIN, Ş., (2020). Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61. Anti-Cancer Drugs , vol.31, no.6, 609-616.
Sahin, Taha Et Al. "Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61," Anti-Cancer Drugs , vol.31, no.6, 609-616, 2020
Sahin, Taha K. Et Al. "Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61." Anti-Cancer Drugs , vol.31, no.6, pp.609-616, 2020
Sahin, T. K. Et Al. (2020) . "Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61." Anti-Cancer Drugs , vol.31, no.6, pp.609-616.
@article{article, author={Taha Koray Sahin Et Al. }, title={Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61}, journal={Anti-Cancer Drugs}, year=2020, pages={609-616} }